ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2798
 
  
 
C07K PEPTIDES 26110
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 24143
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 22184
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1188
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS939
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 2238
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0017,560 REAGENTS, METHODS AND KITS FOR DIAGNOSING PRIMARY IMMUNODEFICIENCIESOct 30, 15Jan 18, 18[G01N]
2018/0009,560 LABELLING DEVICE AND SYSTEM COMPRISING SUCH DEVICEJul 06, 17Jan 11, 18[B65C]
2017/0306,399 METHODS FOR CHARACTERIZING ALTERNATIVELY OR ABERRANTLY SPLICED MRNA ISOFORMSJun 10, 15Oct 26, 17[C12Q, C12N]
2017/0166,974 METHOD FOR THE TREATMENT OF MULTIPLE MYELOMAMay 20, 14Jun 15, 17[A61K, C12Q]
2017/0101,684 METHOD FOR DIAGNOSING AND TREATING MULTIPLE MYELOMAMar 28, 15Apr 13, 17[A61K, C12Q]
2016/0295,842 ANTIBODY PRODUCTIONJul 23, 15Oct 13, 16[C12P, A01K, C07K]
2016/0295,843 Allelic ExclusionDec 08, 15Oct 13, 16[C12N, A01K, C07K]
2014/0024,019 Methods and Means for Monitoring Disruption of Tissue Homeostasis in the Total BodyMar 05, 12Jan 23, 14[G01N]
2012/0184,495 TARGETED NANO-PHOTOMEDICINES FOR PHOTODYNAMIC THERAPY OF CANCERJun 12, 09Jul 19, 12[A61K, C07F, B82Y, C12N, A61P]
2011/0182,825 METHODS AND DEVICES FOR ASSESSMENT OF MITOCHONDRIAL FUNCTIONAug 14, 09Jul 28, 11[A61K, C12Q, C12M, A61B]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9901080 Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cellsMar 11, 16Feb 27, 18[A61K, C12N, A01K]
9901081 Transgenic mouse for determining the role of senescent cells in cancerMar 25, 16Feb 27, 18[A61K, C12N, A01K, G01N]
9880158 Methods, reagents and kits for flow cytometric immunophenotypingJun 02, 10Jan 30, 18[G01N]
9834824 strains and their use in vaccine formulations and as vectors for expression of antigenic sequencesJan 12, 17Dec 05, 17[A61K, C12Q, C12N, G01N, C07K]
9823248 Methods and kits for detecting IgE-expressing B cellsNov 15, 11Nov 21, 17[G01N]
9803016 Anti-CD47 antibodies and methods of useMar 29, 17Oct 31, 17[A61K, C07K]
9803252 Virus causing respiratory tract illness in susceptible mammalsMar 08, 17Oct 31, 17[A61K, C12Q, C12N, G01N, C07K]
9663817 Methods and means for characterizing antibiotic resistance in microorganismsApr 19, 16May 30, 17[C12Q, G01N]
9650441 Anti-CD47 antibodies and methods of useSep 21, 16May 16, 17[A61K, C07K]
9593386 Virus causing respiratory tract illness in susceptible mammalsMay 05, 16Mar 14, 17[A61K, C12Q, C12N, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0152,949 METHOD AND CULTURE MEDIUM FOR IN VITRO CULTURING OF STEM CELLSAbandonedJul 15, 14Jun 02, 16[A61K, C12N]
2015/0160,226 METHOD, REAGENTS, AND KITS FOR DETECTING MINIMAL RESIDUAL DISEASEAbandonedJun 14, 13Jun 11, 15[G01N]
2015/0099,012 METHODS FOR ACTIVATING RETROVIRUS IN LATENT INFECTED CELLS, AND COMPOUNDS FOR USE THEREINAbandonedMar 01, 13Apr 09, 15[A61K]
2015/0079,078 BIOMARKERS FOR TRIPLE NEGATIVE BREAST CANCERAbandonedMar 18, 13Mar 19, 15[C12Q, G01N]
2014/0287,943 ASSAY FOR SHIP1 EXPRESSION, ACTIVITY AND SEQUENCE ALTERATIONS AS A PREDICTOR OF INFLAMMATORY BOWEL DISEASE RISKAbandonedApr 27, 12Sep 25, 14[C12Q, G01N]
2014/0037,616 IMMUNOGLOBULIN 1AbandonedJul 26, 13Feb 06, 14[A01K]
2014/0031,288 NOVEL COMPOSITION FOR TUMOR GROWTH CONTROLAbandonedOct 02, 13Jan 30, 14[A61K]
2014/0033,335 Immunoglobulin 2AbandonedJul 30, 13Jan 30, 14[C07K]
2013/0096,025 MOLECULAR CLASSIFICATION OF MULTIPLE MYELOMAAbandonedMay 27, 11Apr 18, 13[C12Q]
2012/0277,144 NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDSAbandonedNov 04, 10Nov 01, 12[A61K, C07H, C12N, A61P, C07K]
2012/0178,645 IDENTIFYING CIRCULATING TUMOR CELLS (CTCS) USING CD146 IN BREAST CANCER PATIENTSAbandonedJun 26, 09Jul 12, 12[C12Q, G01N, C40B]
2012/0156,241 RESCUE OF INFLUENZA VIRUSAbandonedApr 15, 11Jun 21, 12[A61K, C12N, A61P]
2012/0101,023 METHOD OF DIAGNOSING BLADDER CANCERAbandonedApr 20, 10Apr 26, 12[C07H, A61K, C12Q, C40B]
2012/0088,811 METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIAAbandonedApr 22, 10Apr 12, 12[A61K, C07H, A61P]
2012/0022,026 METHOD OF TREATING CANCERAbandonedJan 13, 10Jan 26, 12[A61K, C12N, A61P]
2012/0003,632 FRET-PROBES AND USE THEREOFAbandonedNov 21, 08Jan 05, 12[C12Q]
2011/0312,534 METHOD FOR PREDICTION OF HUMAN IRIS COLORAbandonedMar 04, 11Dec 22, 11[C07H, C12Q, C40B]
2011/0314,563 ANTIBODY PRODUCTIONAbandonedNov 30, 09Dec 22, 11[C12P, A01K]
2011/0281,270 EFFICIENT DETECTION OF DOUBLE MUTANTS OF THE CEBPA GENE IN ACUTE MYELOID LEUKEMIAAbandonedNov 13, 09Nov 17, 11[C12Q]
2011/0200,584 METHOD TO STIMULATE IMMUNE FUNCTION AND REGENERATIONAbandonedJun 05, 08Aug 18, 11[A61K, C12N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.